Human placental growth hormone causes severe insulin resistance in transgenic mice

被引:133
作者
Barbour, LA [1 ]
Shao, JH
Qiao, LP
Pulawa, LK
Jensen, DR
Bartke, A
Garrity, M
Draznin, B
Friedman, JE
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Med Obstet & Gynecol, Boulder, CO 80309 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Boulder, CO 80309 USA
[3] So Illinois Univ, Sch Med, Dept Physiol, Chicago, IL 60680 USA
[4] Denver Vet Affais Med Ctr, Div Endocrinol, Denver, CO USA
关键词
placental growth hormone; pregnancy; insulin resistance; gestational diabetes;
D O I
10.1067/mob.2002.121256
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The insulin resistance of pregnancy is considered to be mediated by human placental lactogen, but the metabolic effects of human placental growth hormone have not been well defined. Our aim was to evaluate the effect of placental growth hormone on insulin sensitivity in vivo using transgenic mice that overexpress the human placental growth hormone gene. STUDY DESIGN: Glucose and insulin tolerance tests were performed on 6 transgenic mice that overexpressed the human placental growth hormone variant gene and 6 normal littermate controls. The body composition of the mice was assessed by dual-energy radiograph absorptiometry, and free fatty acid levels were measured as a marker of lipolysis. RESULTS: The human placental growth hormone levels in the transgenic mice were comparable to those attained in the third trimester of pregnancy. These mice were nearly twice as heavy as the control mice, and their body composition differed by a significant increase in bone density and a small decrease in percentage of body fat. Fasting insulin levels in the transgenic mice that overexpressed placental growth hormone were approximately 4-fold higher than the control mice (1.57 +/- 0.22 ng/mL vs 0.38 +/- 0.07 ng/mL; P <.001) and 7 times higher 30 minutes after glucose stimulation (4.17 +/- 0.54 ng/mL vs 0.62 +/- 0.10 ng/mL; P <.0001) with no significant difference in either fasting or postchallenge glucose levels. Insulin sensitivity was markedly decreased in the transgenic mice, as demonstrated by an insignificant decline in glucose levels after insulin injection compared with the control mice, which demonstrated more than a 65% reduction in glucose levels (P <.001). CONCLUSION: Human placental growth hormone causes insulin resistance as manifested by fasting and postprandial hyperinsulinemia and minimal glucose lowering in response to insulin injection. Human placental growth hormone is a highly likely candidate to mediate the insulin resistance of pregnancy.
引用
收藏
页码:512 / 517
页数:6
相关论文
共 25 条
  • [1] Physiological role of human placental growth hormone
    Alsat, E
    Guibourdenche, J
    Couturier, A
    Evain-Brion, D
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 140 (1-2) : 121 - 127
  • [2] Anthony RV, 1998, CONT ENDOCRINOL, V9, P461
  • [3] EFFECT OF HOMOLOGOUS PLACENTAL LACTOGENS, PROLACTINS, AND GROWTH-HORMONES ON ISLET B-CELL DIVISION AND INSULIN-SECRETION IN RAT, MOUSE, AND HUMAN ISLETS - IMPLICATION FOR PLACENTAL-LACTOGEN REGULATION OF ISLET FUNCTION DURING PREGNANCY
    BRELJE, TC
    SCHARP, DW
    LACY, PE
    OGREN, L
    TALAMANTES, F
    ROBERTSON, M
    FRIESEN, HG
    SORENSON, RL
    [J]. ENDOCRINOLOGY, 1993, 132 (02) : 879 - 887
  • [4] Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus
    Catalano, PM
    Huston, L
    Amini, SB
    Kalhan, SC
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (04) : 903 - 914
  • [5] Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice
    Dominici, FP
    Cifone, D
    Bartke, A
    Turyn, D
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (03): : E447 - E454
  • [6] TYROSINE PHOSPHORYLATION OF THE GROWTH-HORMONE (GH) RECEPTOR AND JANUS TYROSINE KINASE-2 IS INVOLVED IN THE INSULIN-LIKE ACTIONS OF GH IN PRIMARY RAT ADIPOCYTES
    ERIKSSON, H
    RIDDERSTRALE, M
    TORNQVIST, H
    [J]. ENDOCRINOLOGY, 1995, 136 (11) : 5093 - 5101
  • [7] PLACENTAL GROWTH-HORMONE VARIANT - ASSAY AND CLINICAL ASPECTS
    EVAINBRION, D
    ALSAT, E
    IGOUT, A
    FRANKENNE, F
    HENNEN, G
    [J]. ACTA PAEDIATRICA, 1994, 83 : 49 - 52
  • [8] PERIPHERAL GLUCOSE-METABOLISM IN ACROMEGALY
    FOSS, MC
    SAAD, MJA
    PACCOLA, GMGF
    PAULA, FJA
    PICCINATO, CE
    MOREIRA, AC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (05) : 1048 - 1053
  • [9] Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes
    Friedman, JE
    Ishizuka, T
    Shao, JH
    Huston, L
    Highman, T
    Catalano, P
    [J]. DIABETES, 1999, 48 (09) : 1807 - 1814
  • [10] Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter
    Gaither, K
    Quraishi, AN
    Illsley, NP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) : 695 - 701